Xconomy

AUGUST 26, 2020

The San Diego-based company splashed out $52.5 Acadia agreed to pay CerSci shareholders up to $887 million more in payments depending on development, commercialization, and sales milestones, plus royalties. million on the buyout, a cash-and-stock deal—$47.2

San Diego 102

San Diego Acquisition Sales Develop 102

Xconomy

NOVEMBER 26, 2018

Seismic, one of San Diego’s most prominent enterprise software companies, has tapped a member of the team behind one of the region’s most successful tech startup stories to prep for its own prospective market debut. San Diego native John McCauley was part. Read more » Reprints | Share:

San Diego 89

San Diego Sales Software Development Software 89

Xconomy

JUNE 26, 2019

Mirati Therapeutics plans to raise more than $200 million this week in a public offering, funding that it plans to use to advance its lead cancer drug candidate, sitravatinib, into late-stage testing, and to continue developing its other targeted oncology programs. The San Diego company said Tuesday that it would sell 2.1

San Diego 67

San Diego Sales Funding Develop 67

Xconomy

MARCH 27, 2019

San Diego-based Acadia (NASDAQ: ACAD ) announced in August that it had licensed the drug, trofinetide, for development and commercialization in North America as a treatment for Rett syndrome and other indications, including Fragile X syndrome. The results of the. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 97

San Diego .Net Sales Develop 97

Xconomy

DECEMBER 18, 2018

A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche , Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies.

San Diego 86

San Diego Startup Sales Invest 86

Xconomy

JUNE 24, 2019

Conatus Pharmaceuticals said Monday that it would cut its staff by 40 percent and consider a sale or merger after a drug it was testing as a treatment for an increasingly common form of chronic liver disease failed to beat a placebo in a mid-stage clinical trial—the latest letdown in a number of trial failures.

Sales 70

Sales Company Companies Develop 70

Xconomy

JULY 7, 2016

Morristown, NJ-based Pernix (NASDAQ: PTX ) will cut 60 workers , mostly from its neurology sales staff, the company said today. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. As of the end of 2015, Pernix reported a headcount of 274. Last year, Pernix reported a $148.3

Sales 40

Sales San Diego .Net Report 40

Xconomy

AUGUST 22, 2016

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego. We have an endless time horizon.

Develop 40

Develop Development San Diego Startup 40

Xconomy

NOVEMBER 5, 2018

Japanese life sciences company Kyowa Hakko Kirin has agreed to pay the San Diego company $10 million upfront for rights to develop and commercialize ME-401 in Japan. million more if the drug, a PI3K delta inhibitor, meets a variety of milestones; plus royalties from sales if it reaches the market.

San Diego 70

San Diego Sales Marketing Develop 70

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts. Cibus’s first commercial product is SU Canola, a variety of canola that is tolerant to sulfonylurea, a type of herbicide.

San Diego 61

San Diego Marketing Research Invest 61

Xconomy

SEPTEMBER 14, 2017

The San Diego biotech company’s list of alliances is now getting longer. Bristol-Myers Squibb (NYSE: BMY ) announced Thursday that it will pay $105 million up front to license Halozyme’s (NASDAQ: HALO ) technology to develop injectable immuno-oncology drugs. The deal covers up to 11 potential drugs, including a class of.

San Diego 64

San Diego Class Sales Technology 64

Xconomy

JUNE 30, 2016

Healthtech entrepreneur Parker Hinshaw and his wife Jean Balgrosky said they intended to take a step back when they founded Bootstrap Incubation near San Diego in the fall of 2012. They came to San Diego in 1996, when Scripps Health hired Balgrosky as CIO and senior vice president. He founded MaxIT Healthcare in 2001.

San Diego 67

San Diego CIO Incubator Startup 67

Xconomy

DECEMBER 7, 2018

Aha makes a program that helps project managers develop new product roadmaps, which are used by others in the customer’s business, from sales. Read more » Reprints | Share:

Sales 100

Sales Software Services Startup 100

Xconomy

OCTOBER 10, 2016

By popular acclaim, San Diego-based Echo Laboratories founder Eugene Cho claimed top honors, and a $15,000 check, for his two-minute presentation last week in the 10th annual “Quick Pitch” competition, hosted by San Diego’s Tech Coast Angels. He told the audience Revolve sales had generated $1.8 Echo Labs image).

Tech Coast Angels 40

Tech Coast Angels Technical Review San Diego Software Review 40

Xconomy

AUGUST 1, 2016

PacketSled, a cybersecurity startup based in suburban San Diego, has raised $5 million in a Series A funding round led by Keshif Ventures, a local angel investment fund that has put money into dozens of tech startups in the San Diego area. Two other small funds, Blu Ventures and JHS Ventures joined in the round.

San Diego 40

San Diego Conference Funding Networking 40

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. Entrepreneurs at work on first day of Canopy San Diego accelerator program.

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

JUNE 19, 2020

The biggest life sciences deal this week involves a company that doesn’t discover or develop drugs, or even sell them. Most of those royalties are for products that are already approved, but the company has also been striking deals for compounds still in development. Royalty Pharma rakes in royalty cash from drug sales.

Sales 71

Sales Product Develop Development 71

Xconomy

MAY 6, 2019

The La Jolla-CA-based company, spun out of research from The Scripps Research Institute (TSRI), is developing drugs to treat diseases of the central nervous system, among them Tourette syndrome. Lundbeck could pay Abide shareholders up to another $150 million if the company’s drugs hit certain development and sales.

Research 98

Research Sales Develop Development 98

Xconomy

JULY 12, 2016

— 5D Robotics , founded in 2009 in Carlsbad, CA, (about 30 miles north of San Diego), has developed a device that integrates GPS, inertial guidance, optical positioning, and other technologies. SlantRange, a San Diego company founded almost three years ago, is a drone-related startup already generating sales.

San Diego 40

San Diego Seed Funding Guide Technology 40

Xconomy

JANUARY 19, 2017

San Antonio — Cytori Therapeutics, a San Diego, CA-based developer of drugs that use patients’ own fat tissues to make cellular therapies, is buying the assets of San Antonio-based Azaya Therapeutics in a mostly stock deal, with potential future payments that are dependent on the progress of two drug candidates Cytori is acquiring.

San Diego 40

San Diego Develop Development Sales 40

Xconomy

AUGUST 8, 2016

It’s been less than a year since Needham, MA-based PTC (NASDAQ: PTC ) shelled out $65 million to acquire Vuforia, the augmented reality technology created by San Diego-based Qualcomm (NASDAQ: QCOM ). Vuforia’s headquarters has remained in San Diego, and Vuforia continues to operate four offices in Europe and Israel, Wright said.

San Diego 40

San Diego Mobile Examples .Net 40

Xconomy

DECEMBER 11, 2018

This week, the FDA cleared “reSET-O,” an app developed by “digital therapeutics” startup Pear Therapeutics, for sale in the U.S. Doctors and other caregivers have a new weapon to combat the opioid epidemic. But it’s not a pharmaceutical drug—it’s a mobile app.

Mobile 82

Mobile Sales Startup Help 82

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service.

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

AUGUST 2, 2019

We’re in the midst of earnings season, and a couple of San Diego’s publicly traded biotechs recently updated investors this week with sales data and other financial insights. Here’s a look at those companies.

Pricing 61

Pricing Sales Company Companies 61

Xconomy

MAY 9, 2017

The new cash, which brings Edico’s total funding to $32 million, will be used to fuel expansion and further development of Edico’s Dragen technology. There’s a lot of additional engineering and software development that needs to be done, and Edico also plans to expand its sales and marketing team, CEO Pieter.

Web 77

Web Services Software Development Sales 77

Xconomy

AUGUST 8, 2016

After reporting encouraging news last week from a mid-stage trial of its lead anti-cancer drug, San Diego’s MEI Pharma (NASDAQ: MEIP ) said it has signed a drug development deal with the Swiss pharmaceutical group Helsinn that could eventually be worth over $464 million. Reprints | Share:

Study 40

Study San Diego News Design 40

Xconomy

FEBRUARY 9, 2017

Now, as we continue to grow our editorial coverage, we are excited to be significantly expanding our sales and business development efforts as well. In the past year alone, we have launched new channels covering robotics and A.I., cybersecurity, and education, joining seven existing areas of special focus.

High Tech 40

High Tech Education News Sales 40

Xconomy

OCTOBER 16, 2016

After raising $30 million, San Diego-based Certona said it is moving to accelerate its product development, expand its sales and marketing team, and improve its client services as an e-commerce technology vendor.

Artificial Inteligence 40

Artificial Inteligence Commerce San Diego Web 40

Xconomy

JULY 1, 2016

If you want fireworks this weekend, you can either celebrate the 4th of July or watch the latest post-Brexit political developments in Britain. Shares were down nearly 8 percent in aftermarket trading… Boehringer Ingelheim said it would lay off 724 jobs , mainly in sales, across the U.S., This week, UPenn revealed more details.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

OCTOBER 14, 2016

. —Shares of San Diego-based Illumina (NASDAQ: ILMN ) fell more than 32 percent after the next-gen sequencing giant slashed its revenue projections once again. But sagging sales have sent Illumina far down from last year’s peak. . in July 2015. million shares at $15 to $17 apiece. million in an IPO. .

News 40

News San Diego Incubator Research 40

Xconomy

NOVEMBER 11, 2016

CRISPR DEVELOPMENTS. billion in yearly sales. —Alexion Pharmaceuticals (NASDAQ: ALXN ), of New Haven, CT, delayed filing its quarterly earnings report to investigate allegations made by a former employee about improper sales practices at the company. 6 at the U.S. Patent and Trademark Office. FDA GIVETH AND TAKETH….

Patents 87

Patents Study Pricing Research 87

Xconomy

APRIL 20, 2017

San Antonio — George Perry, a scientist at the University of Texas at San Antonio, has long proposed that drug developers and researchers need to look earlier into the roots of Alzheimer’s disease. A potential discovery that targets the early development of the disease—in.

Study 68

Study Research Develop Development 68

Xconomy

JULY 29, 2016

But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. The study is one of several Celgene is running to try to expand the use of its blockbuster blood cancer drug.

Startup 40

Startup Study News Report 40

Xconomy

JULY 21, 2016

This is the right time for a new leader to take the reins and lead Biogen through its next stage of development, and I look forward to returning to the West coast to take on one more set of activities and spend more time with my family.”. George joined Biogen at a very challenging time.

San Diego 40

San Diego Conference Pricing Acquisition 40

Xconomy

JULY 15, 2016

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. The week started on a reflective note. And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. —In other Merck news, U.K.-based

News 40

News Technical Review San Diego Startup 40

Xconomy

AUGUST 5, 2016

Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. Instead, Holmes promoted a new system, MiniLab , in development. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

OCTOBER 18, 2016

Sales of both drugs, ivacaftor (Kalydeco) and the combo pill ivacaftor-lumacaftor (Orkambi), reached almost $1 billion in 2015 and are growing. Telaprevir sales rocketed to nearly $1 billion in the first six months, at the time the fastest drug launch ever. But the drugs aren’t cures, and competition looms.

Startup 40

Startup Research Sales Organization 40